A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Clinical trial NCT07401875 · RECRUITING
Trial details
- NCT number
- NCT07401875
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2027-11-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.